Birch Pollen Allergy
📧 Sign up to get email alerts when something new happens for Birch Pollen Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy [Phase 3]
Phase 3 study evaluating REGN5713-5715 for reducing signs and symptoms of ocular allergy in adults with birch pollen allergy (allergic conju…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy [Phase 3]
A Phase 3 study evaluating Bet v1 antibodies for eye allergy symptoms in adolescents and adults with birch pollen allergy. The trial is curr…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma [Phase 3]
Phase 3 trial evaluating the safety and efficacy of STALORAL Birch 300 IR in children with birch pollen-induced allergic rhinoconjunctivitis…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis [NA]
A clinical trial evaluating threshold pollen concentrations for ragweed and birch pollen in seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Evaluation of an Adjusted Cutoff Value for S.P.A.T (Skin Prick Automated Test) Device in Allergic Subjects [NA]
This clinical trial update reports the completion of evaluating an adjusted cutoff value for the Skin Prick Automated Test (SPAT) device in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Evaluation of the Efficacy of Oral Immunotherapy with Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study [Phase 3]
A Phase 3 multicenter trial is evaluating the efficacy of raw-apple oral immunotherapy for individuals with birch pollen allergy and apple a…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy [Phase 1]
Phase 1 trial assessing safety and tolerability of sc immunotherapy DM-101 in adults with birch pollen allergy has completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy [Phase 2]
A Phase 2 trial evaluating sublingual immunotherapy for birch pollen-related apple allergy has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment
This update reports follow-up results from Study AN004T evaluating the persistence of AllerT efficacy against Birch pollen allergy during se…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens [Phase 3]
Phase 3 trial update reporting safety and efficacy of aluminium hydroxide-adsorbed birch pollen allergoid immunotherapy for birch pollen all…
-
CLINICAL_TRIALS research · 2014-05-23Clinical Trial Update: Effect of the Nasal Provocation on the Breathing Style [NA]
Clinical trial update examining the effect of nasal provocation on breathing style in individuals with birch pollen allergy and healthy cont…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen Exposure [NA]
The completed University of Zurich trial evaluated how different skin conditions influence the skin's allergic response to epicutaneous alle…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet [Phase 2]
A Phase 2 dose-response study of ALK's Tree Allergy Immunotherapy Tablet for birch pollen allergy has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Efficacy and Safety From a Recombinant Folding Variant of Bet v 1 [Phase 3]
Phase 3 trial update of a recombinant Bet v 1 allergen assessing efficacy and safety in birch pollen allergy. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 trial evaluating the safety and efficacy of a recombinant birch pollen allergen for allergic rhinoconjunctivitis due to birch pollen…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV [Phase 2]
A Phase 2 trial evaluating recombinant birch pollen allergen rBet v1-FV for birch pollen allergy has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch [Phase 2]
Phase 2 study evaluating efficacy and tolerability of two administration routes for SLITonePLUS Birch in birch pollen–related allergic rhini…
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation [Phase 1]
Phase 1 physiological study completed to determine allergic skin activity after different skin preparations in participants with birch polle…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: SUBLIVAC® Birch PROBE Study [Phase 2]
A Phase 2 trial of SUBLIVAC Birch PROBE for birch pollen allergy and seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS research · 2011-05-16Clinical Trial Update: Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1 [Phase 1]
Phase 1 study evaluating immune response to hypoallergenic derivatives of Bet v 1, the major birch pollen allergen.